1. DOP018 Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn's disease. (16th January 2018) Authors: Creyns, B; Verstockt, B; Cremer, J; Ferrante, M; Vermeire, S; Jan, C; Van Assche, G; Breynaert, C Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP26 Biological therapy increases NCR+ ILC3 levels in IBD patients. (25th January 2019) Authors: Creyns, B; Verstockt, B; Cremer, J; Ballet, V; Ferrante, M; Vermeire, S; Ceuppens, J; Van Assche, G; Breynaert, C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S040 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP70 An integrated multi-omics biomarker predicting endoscopic response in ustekinumab treated patients with Crohn's disease. (25th January 2019) Authors: Verstockt, B; Sudahakar, P; Creyns, B; Verstockt, S; Cremer, J; Wollants, W-J; Organe, S; Korcsmaros, T; Madgwick, M; Van Assche, G; Breynaert, C; Vermeire, S; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S072 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P001 Multi-omic data integration assisted identification of molecular features contributing to disease heterogeneity in Crohn's disease. (25th January 2019) Authors: Sudhakar, P; Verstockt, B; Creyns, B; Cremer, J; van Assche, G; Korcsmaros, T; Ferrante, M; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S085 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P035 Serum markers predict outcome to ustekinumab in patients with refractory Crohn's disease and provide insides in the mechanism of action. (16th January 2018) Authors: Verstockt, B; Vermeire, S; Verstockt, S; Creyns, B; Ardeshir Davani, N; Breynaert, C; Van Assche, G; Van Assche, G; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P063 The immunological landscape of intestinal fibrosis in Crohn's Disease. (27th May 2021) Authors: Jacobs, I; Creyns, B; Dragoni, G; Cremer, J; Bislenghi, G; D'Hoore, A; Ke, B J; Matteoli, G; De Hertogh, G; Ferrante, M; Joao, G S; Breynaert, C; Vermeire, S; Verstockt, B; Vanuytsel, T Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗